Anecortave (Alcon Laboratories).
Anecortave, an angiostatic steroid administered as a posterior juxtascleral depot, is under development by Alcon Laboratories Inc for the potential prevention and treatment of ocular diseases, in particular age-related macular degeneration.
Angiogenesis Inhibitors↗